CRISRP/Cas9 technology generated an ACC to GTG change at nt1950719510 resulting in a threonine to valine substitution at amino acid 232 (p.T232V) in exon 4, resulting in a hypermorphic allele. (J:338825)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count